Last reviewed · How we verify
NCT03849625
Characteristics of Patients Diagnosed With NSAID Sensitivity in Thailand
trial testing aspirin, NSAIDs, paracetamol in Aspirin Sensitivity in 158 participants. Completed in 31 March 2020.
28 February 2020
Quick facts
| Lead sponsor | Chulalongkorn University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 158 |
| Start date | 1 May 2015 |
| Primary completion | 28 February 2020 |
| Estimated completion | 31 March 2020 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- aspirin, NSAIDs, paracetamol — full drug profile →
Conditions studied
- Aspirin Sensitivity — all drugs for Aspirin Sensitivity →
- Aspirin-exacerbated Respiratory Disease — all drugs for Aspirin-exacerbated Respiratory Disease →
- Aspirin-Induced Angioedema-Urticaria — all drugs for Aspirin-Induced Angioedema-Urticaria →
- Aspirin Allergy — all drugs for Aspirin Allergy →
Sponsor
Chulalongkorn University
Who can join
15 and older, any sex, with Aspirin Sensitivity or Aspirin-exacerbated Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study clinical characteristics and phenotypes of patients diagnosed with NSAID sensitivity in Thailand
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical Characteristics, Urinary Leukotriene E4 Levels, and Aspirin Desensitization Results in Patients With NSAID-Induced Blended Reactions.
Klaewsongkram J, Buranapraditkun S, Mongkolpathumrat P, Palapinyo S, et al · · 2021 · cited 6× · PMID 33474858 · DOI 10.4168/aair.2021.13.2.229
Verify or expand the search:
- PubMed search for NCT03849625
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Chulalongkorn University trials
Trials by the same sponsor.
- NCT07458659 — Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myel · EARLY_PHASE1 · not yet recruiting
- NCT07346118 — Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury · NA · not yet recruiting
- NCT07388862 — Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent · EARLY_PHASE1 · not yet recruiting
- NCT07373977 — Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Ma · EARLY_PHASE1 · not yet recruiting
- NCT07078929 — Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03849625 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chulalongkorn University
- Last refreshed: 25 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03849625.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing